Ocular Surface Squamous Neoplasia Masquerading as Diverse Ocular Surface Lesions: A Five-Case Series Highlighting Diagnostic Pitfalls and Management
Abstract
Purpose: To describe the varied clinical presentations of ocular surface squamous neoplasia (OSSN), the diagnostic pitfalls that delayed recognition, and the management outcomes in five patients treated at a tertiary eye-care centre in Uttar Pradesh.
Case Series: This retrospective descriptive case series includes five patients (three men and two women; mean age, 55.8 years; range, 42–72 years). Lesions were initially considered to represent inflamed pterygium/pinguecula, nodular scleritis, foreign-body granuloma, conjunctival papilloma, or conjunctival lymphoma. The largest lesion measured approximately 14 × 10 mm. Anterior-segment optical coherence tomography (AS-OCT), when documented, demonstrated thickened hyperreflective epithelium with an abrupt transition from normal to abnormal epithelium. Three patients received primary topical chemotherapy (interferon alfa-2b in two and mitomycin-C in one); two patients with larger lesions received mitomycin-C for chemoreduction followed by excision biopsy. Histopathology confirmed high-grade conjunctival intraepithelial neoplasia/carcinoma in situ in the surgically treated cases. No local recurrence was documented during the available follow-up (12–19 months in four cases; follow-up in the fifth case was reported as 15 months in the case narrative). One patient died from systemic complications of chronic kidney disease, without documented ocular recurrence before death.
Conclusion: OSSN can mimic inflammatory and benign conjunctival disorders, including scleritis, pterygium, granuloma, papilloma, and lymphoma. Persistent, enlarging, vascularized, or treatment-resistant lesions warrant reassessment, appropriate imaging and histopathological confirmation when indicated. Early recognition may permit less invasive treatment and reduce ocular-surface morbidity.
Keywords:
ocular surface squamous neoplasia, conjunctival intraepithelial neoplasia, anterior-segment optical coherence tomography, interferon alfa-2b, mitomycin-C, diagnostic delayDOI
https://doi.org/10.37022/wjcmpr.v8i3.471References
1. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995;39(6):429-450. doi:10.1016/S0039-6257(05)80054-2.
2. Nanji AA, Sayyad FE, Karp CL. Clinical management of ocular surface squamous neoplasia: a review of the current evidence. Ophthalmology. 2017;124(4):547-555. doi:10.1016/j.ophtha.2016.12.015.
3. Shields CL, Chien JL, Surakiatchanukul T, Sioufi K, Lally SE, Shields JA. Conjunctival tumors: review of clinical features, risks, biomarkers, and outcomes—the 2017 J. Donald M. Gass Lecture. Asia Pac J Ophthalmol (Phila). 2017;6(2):109-120. doi:10.22608/APO.201710.
4. Kieval JZ, Karp CL, Abou Shousha M, et al. Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia. Ophthalmology. 2012;119(3):481-486. doi:10.1016/j.ophtha.2011.08.028.
5. Monroy D, Serrano A, Galor A, Karp CL. Medical treatment for ocular surface squamous neoplasia. Eye (Lond). 2023;37:195-205. doi:10.1038/s41433-022-02214-5.
Published
Abstract Display: 0
PDF Downloads: 0 How to Cite
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
